Hypokalemic Periodic Paralysis
📧 Sign up to get email alerts when something new happens for Hypokalemic Periodic Paralysis.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2015-08-07FDA Approved: KEVEYIS — Supplemental Application (Xeris Pharmaceuticals, Inc.)
FDA approved a supplemental application for KEVEYIS (dichlorphenamide) from Xeris Pharmaceuticals, updating the product labeling.